Public annual accounts

FARMACONSULT financials

Name: FARMACONSULT financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for FARMACONSULT, with comparable measures and links to available source documents.

Company overview

Registry number

0860118992

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

Latest movements for FARMACONSULT

2025 versus 2024

Operating line: €125,339
EBITDA: €122,668
Total assets: €1,938,095
Equity: €1,823,031

EBITDA margin +97.9% · Equity ratio +94.1%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€125,339	€122,668	€1,938,095	€1,823,031	-
202431 Dec 2024	€36,309	€34,831	€1,892,231	€1,650,996	-

Gross margin as filed under the abbreviated schema. This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

FARMACONSULT financials

Latest movements for FARMACONSULT

Filed annual accounts by fiscal year

Explore the underlying reports

Valuation